PTK2 and colorectal carcinoma: Conceivably, the integrin‐FAK axis is a potential driver of a wide spectrum of pro‐tumorigenic and pro‐metastatic activities or processes in CRC and is worthy of further study of its molecular action and therapeutic potential.